Bimekizumab Safe, Efficacious Over Two Years for Hidradenitis Suppurativa
Clinically meaningful efficacy outcomes observed at one year maintained to two years of treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.